We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSII
9351
CALL
DELISTED
Cardiovascular Systems, Inc.
CSII
$236K ﹤0.01%
+5,400
New +$203K
FEUL
9352
DELISTED
Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ
FEUL
$236K ﹤0.01%
+2,660
New +$209K
CCMP
9353
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$236K ﹤0.01%
1,560
-3,085
-66% -$462K
GNCA
9354
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
$236K ﹤0.01%
97,600
+75,100
+334% +$171K
AU icon
9355
AngloGold Ashanti
AU
$44.3B
$235K ﹤0.01%
10,369
-98,627
-90% -$2.37M
BGFV
9356
DELISTED
Big 5 Sporting Goods
BGFV
$235K ﹤0.01%
+22,990
New +$204K
CULP icon
9357
PUT
Culp Inc
CULP
$44.8M
$235K ﹤0.01%
14,800
-9,300
-39% -$133K
HIBS icon
9358
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$18.7M
$235K ﹤0.01%
+70
New +$443K
SCOR icon
9359
PUT
Comscore
SCOR
$113M
$235K ﹤0.01%
4,720
+3,000
+174% +$133K
ACCD
9360
PUT
DELISTED
Accolade Inc
ACCD
$235K ﹤0.01%
+5,400
New +$240K
AKTS
9361
PUT
DELISTED
Akoustis Technologies Inc
AKTS
$235K ﹤0.01%
19,200
-10,200
-35% -$89.4K
BRFS
9362
PUT
DELISTED
BRF SA
BRFS
$234K ﹤0.01%
55,600
-5,900
-10% -$22K
FCOR icon
9363
Fidelity Corporate Bond ETF
FCOR
$348M
$234K ﹤0.01%
+4,088
New +$231K
IDT icon
9364
IDT Corp
IDT
$1.65B
$234K ﹤0.01%
+18,973
New +$210K
OPLN
9365
PUT
Openlane
OPLN
$4.62B
$234K ﹤0.01%
12,600
-5,900
-32% -$102K
KTCC icon
9366
PUT
Key Tronic
KTCC
$44.7M
$234K ﹤0.01%
+33,900
New +$277K
WSR
9367
DELISTED
Whitestone REIT
WSR
$234K ﹤0.01%
+29,345
New +$211K
AHCO icon
9368
PUT
AdaptHealth
AHCO
$806M
$233K ﹤0.01%
+6,200
New +$192K
CERS icon
9369
Cerus
CERS
$468M
$233K ﹤0.01%
33,701
-4,379
-11% -$28.7K
CW icon
9370
PUT
Curtiss-Wright
CW
$26.4B
$233K ﹤0.01%
2,000
-6,400
-76% -$676K
DLB icon
9371
PUT
Dolby
DLB
$5.71B
$233K ﹤0.01%
2,400
-2,200
-48% -$182K
MXL icon
9372
PUT
MaxLinear
MXL
$6.37B
$233K ﹤0.01%
6,100
-2,900
-32% -$84.2K
OPY icon
9373
PUT
Oppenheimer Holdings
OPY
$1.22B
$233K ﹤0.01%
+7,400
New +$209K
VRA icon
9374
CALL
Vera Bradley
VRA
$96.1M
$233K ﹤0.01%
29,300
+8,200
+39% +$62.1K
CCU icon
9375
Compañía de Cervecerías Unidas
CCU
$2.21B
$232K ﹤0.01%
+15,767
New +$215K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.